Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

11.98
Delayed Data
As of Jul 02
 -0.12 / -0.99%
Today’s Change
5.53
Today|||52-Week Range
13.84
+5.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-79.7M-91.8M-130.7M-83.6M
 
 
 
 
 
Depreciation5.3M3.7M2.6M3.2M
 
 
 
 
 
Total Other Cash Flow7.1M6.4M15.9M22.6M
 
 
 
 
 
Funds From Operations-66.1M-81.7M-112.2M-57.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-13.2M-1.9M-17.1M-23.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-52.8M-79.8M-95.2M-34.8M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-115.7M-112.9M-111.8M
 
 
 
 
Decrease In Investments0.0043.9M95.1M111.9M
 
 
 
 
Capital Expenditures-3.8M-3.2M-9.9M-6.0M
 
 
 
 
 
Other Investing - Uses0.00-628.0K-59.0K-2.0K
 
 
 
 
Other Investing - Sources7.0K381.0K0.000.00
 
 
 
Net Cash Flow Investing-3.7M-75.2M-27.7M-6.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.0041.1M121.5M1.0M
 
 
 
 
Long Term Debt Reduction-443.0K-48.0K0.000.00
 
 
 
Net Proceeds Stock Sale78.7M105.5M28.8M10.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.00-4.2M-3.0K-7.0K
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing1.9M0.000.000.00
 
 
Net Cash Flow - Financing76.3M142.3M150.3M11.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash19.7M-12.7M27.4M-29.4M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account